Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
AGN
Allergan plc
AGN
|
+$603M |
| 3 |
Meta Platforms (Facebook)
META
|
+$459M |
| 4 |
Alibaba
BABA
|
+$361M |
| 5 |
Amazon
AMZN
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Value ETF
IWD
|
+$2.49B |
| 2 |
Qualcomm
QCOM
|
+$424M |
| 3 |
Oracle
ORCL
|
+$369M |
| 4 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$351M |
| 5 |
RHT
Red Hat Inc
RHT
|
+$311M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.16% |
| 2 | Financials | 5.29% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Communication Services | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TVRD
3426
Tvardi Therapeutics
TVRD
$19.7M
| $1.16M | ﹤0.01% |
1,763
-1,733
| -50% | -$1.44M |
|
3427
Boston Beer
SAM
$1.91B
| $1.16M | ﹤0.01% |
3,182
-2,124
| -40% | -$835K |
|
|
MXIM
3428
PUT
DELISTED
Maxim Integrated Products
MXIM
| $1.16M | ﹤0.01% |
20,000
+1,400
| +8% | +$81.1K |
|
3429
PUT
Canadian Pacific Kansas City
CP
$78.1B
| $1.16M | ﹤0.01% |
26,000
+14,000
| +117% | +$659K |
|
|
IMMU
3430
PUT
DELISTED
Immunomedics Inc
IMMU
| $1.16M | ﹤0.01% |
87,200
+40,100
| +85% | +$589K |
|
3431
Allogene Therapeutics
ALLO
$649M
| $1.16M | ﹤0.01% |
42,379
-50,790
| -55% | -$1.45M |
|
3432
Cytokinetics
CYTK
$10.5B
| $1.16M | ﹤0.01% |
101,485
+21,993
| +28% | +$276K |
|
3433
ONE Gas
OGS
$4.87B
| $1.15M | ﹤0.01% |
12,008
+1,563
| +15% | +$143K |
|
|
GLIBA
3434
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $1.15M | ﹤0.01% |
18,577
-28,208
| -60% | -$1.75M |
|
3435
La-Z-Boy
LZB
$1.58B
| $1.15M | ﹤0.01% |
34,249
-9,841
| -22% | -$315K |
|
3436
Globus Medical
GMED
$10.7B
| $1.15M | ﹤0.01% |
22,462
+2,165
| +11% | +$103K |
|
3437
PUT
Dow Inc
DOW
$21.9B
| $1.15M | ﹤0.01% |
24,100
+1,200
| +5% | +$56.2K |
|
3438
CALL
Fox Class A
FOXA
$24.5B
| $1.15M | ﹤0.01% |
36,300
-49,100
| -57% | -$1.7M |
|
3439
PUT
NOV
NOV
$6.93B
| $1.15M | ﹤0.01% |
54,000
-6,131,800
| -99% | -$131M |
|
3440
Valmont Industries
VMI
$9.3B
| $1.14M | ﹤0.01% |
8,235
+308
| +4% | +$41.3K |
|
3441
Zoom
ZM
$28.2B
| $1.14M | ﹤0.01% |
14,922
-7,529
| -34% | -$678K |
|
3442
PUT
AngloGold Ashanti
AU
$40.1B
| $1.13M | ﹤0.01% |
62,100
+17,300
| +39% | +$343K |
|
|
FITB
3443
CALL
Fifth Third Bancorp
FITB
$51.2B
| $1.13M | ﹤0.01% |
41,400
+12,600
| +44% | +$345K |
|
3444
PUT
Ameriprise Financial
AMP
$48.3B
| $1.13M | ﹤0.01% |
7,700
+6,800
| +756% | +$953K |
|
3445
CALL
MPLX
MPLX
$59.3B
| $1.13M | ﹤0.01% |
40,400
+1,600
| +4% | +$46.9K |
|
3446
Southern Copper
SCCO
$143B
| $1.13M | ﹤0.01% |
35,794
+23,104
| +182% | +$733K |
|
|
VGR
3447
DELISTED
Vector Group Ltd.
VGR
| $1.13M | ﹤0.01% |
134,066
+47,409
| +55% | +$363K |
|
3448
Vanguard World Funds Extended Duration ETF
EDV
$3.22B
| $1.13M | ﹤0.01% |
8,002
+1,381
| +21% | +$188K |
|
3449
Advanced Drainage Systems
WMS
$10.6B
| $1.13M | ﹤0.01% |
35,063
-5,223
| -13% | -$170K |
|
|
EPAY
3450
DELISTED
Bottomline Technologies Inc
EPAY
| $1.13M | ﹤0.01% |
28,755
-22,132
| -43% | -$930K |
|
Similar funds
Citigroup's Q3 2019 Portfolio in Review
As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.
- Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
- Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
- Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
- Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
- Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
- Citigroup opened 182 new positions and closed 268 in Q3 2019.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.
Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.